Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-23-000541
Filing Date
2023-01-23
Accepted
2023-01-23 16:28:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 KINNATE BIOPHARMA INC. p23-0318sc13g.htm SC 13G 68330
  Complete submission text file 0000902664-23-000541.txt   69861
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Subject) CIK: 0001797768 (see all company filings)

EIN.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91893 | Film No.: 23544794
SIC: 2834 Pharmaceutical Preparations

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Filed by) CIK: 0001910456 (see all company filings)

EIN.: 851134656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G